One thing for sure, ensogo is substantially under institutional funds control. We retail investors have to be really patient or move on. Lets see the quarterly news coming this month end.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025